JP2008528701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008528701A5 JP2008528701A5 JP2007554268A JP2007554268A JP2008528701A5 JP 2008528701 A5 JP2008528701 A5 JP 2008528701A5 JP 2007554268 A JP2007554268 A JP 2007554268A JP 2007554268 A JP2007554268 A JP 2007554268A JP 2008528701 A5 JP2008528701 A5 JP 2008528701A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- protein
- pharmaceutical composition
- group
- delta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64923005P | 2005-02-02 | 2005-02-02 | |
| PCT/US2006/003972 WO2006084197A2 (en) | 2005-02-02 | 2006-02-02 | Nitroxides for use in treating or preventing neoplastic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008528701A JP2008528701A (ja) | 2008-07-31 |
| JP2008528701A5 true JP2008528701A5 (https=) | 2008-11-06 |
Family
ID=36777996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007554268A Pending JP2008528701A (ja) | 2005-02-02 | 2006-02-02 | 腫瘍性疾患の治療又は予防に用いるためのニトロキシド類 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20120046314A1 (https=) |
| JP (1) | JP2008528701A (https=) |
| WO (1) | WO2006084197A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2325908C1 (ru) * | 2006-09-20 | 2008-06-10 | Государственное учреждение научно-исследовательский институт онкологии Томского Научного центра Сибирского отделения Российской академии медицинских наук (ГУ НИИ онкологии ТНЦ СО РАМН) | Способ профилактики осложнений при комбинированном лечении больных раком легкого и желудка |
| EP2030624A1 (en) | 2007-08-28 | 2009-03-04 | Johannes Gutenberg Universität | Antioxidant and paramagnetic heparin-nitroxide derivatives |
| US8460862B2 (en) * | 2009-03-11 | 2013-06-11 | Marker Gene Technologies | Enzyme substrates for visualizing acidic organelles |
| US8853277B2 (en) | 2009-11-30 | 2014-10-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC) |
| US20180078539A1 (en) * | 2016-03-23 | 2018-03-22 | Louis Habash | T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxide |
| US10159665B2 (en) | 2016-03-23 | 2018-12-25 | Louis Habash | Preventing amyloid plaque formation by treating a human subject with a nitroxide |
| JP2019509352A (ja) * | 2016-03-23 | 2019-04-04 | ルイス ハバシュ， | ヒトの被験物質をニトロキシドで処理することによってａｐｏｐｔｏｓｉｓ関連遺伝子の発現レベルを増加させる |
| US9545398B1 (en) * | 2016-03-23 | 2017-01-17 | Louis Habash | Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide |
| US10231959B2 (en) | 2016-03-23 | 2019-03-19 | Louis Habash | Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide |
| US10441578B2 (en) | 2018-01-19 | 2019-10-15 | Louis Habash | Altering expression level of glutathione S-transferase genes by treating a human subject with a nitroxide |
| US10828291B2 (en) | 2018-01-22 | 2020-11-10 | Louis Habash | Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide |
| US20220378771A1 (en) * | 2021-05-25 | 2022-12-01 | Louis Habash | Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxide |
| US20220378767A1 (en) * | 2021-05-25 | 2022-12-01 | Louis Habash | Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxide |
| US11510913B1 (en) | 2021-05-25 | 2022-11-29 | Louis Habash | Modulating expression level of a gene encoding an apurinic/apyrimidinic endodeoxyribonuclease protein by treating a human subject with a nitroxide |
| US12208089B2 (en) * | 2021-05-25 | 2025-01-28 | Louis Habash | Adjusting expression level of a gene encoding a Sirtuin protein by treating a human subject with a nitroxide |
| US11324737B1 (en) * | 2021-05-25 | 2022-05-10 | Louis Habash | Modulating expression level of a gene encoding a heat shock protein by treating a human subject with a nitroxide |
| CN118649240A (zh) * | 2024-07-09 | 2024-09-17 | 哈尔滨医科大学附属肿瘤医院(哈尔滨医科大学附属第三医院、哈尔滨医科大学第三临床医学院、黑龙江省肿瘤医院) | 低氧抑制剂联合sting激动剂在制备用于治疗肿瘤药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE262330T1 (de) * | 1997-05-27 | 2004-04-15 | Us Gov Health & Human Serv | Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs |
| AU765110B2 (en) * | 1998-06-26 | 2003-09-11 | Georgetown University Medical Center | Compositions and methods for inducing cell death |
-
2006
- 2006-02-02 WO PCT/US2006/003972 patent/WO2006084197A2/en not_active Ceased
- 2006-02-02 JP JP2007554268A patent/JP2008528701A/ja active Pending
- 2006-02-02 US US11/815,444 patent/US20120046314A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008528701A5 (https=) | ||
| CN113767106A (zh) | 氧杂氮杂喹唑啉-7(8h)-酮类化合物,其制法与医药上的用途 | |
| JP2009524695A5 (https=) | ||
| JP2009511595A5 (https=) | ||
| JP2011500713A5 (https=) | ||
| JP2013509429A5 (https=) | ||
| JP2009502743A5 (https=) | ||
| JP2010529118A5 (https=) | ||
| JP2010502730A5 (https=) | ||
| JP2010241830A5 (https=) | ||
| JP2010507096A5 (https=) | ||
| IL193678A (en) | Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity | |
| JP2009515980A5 (https=) | ||
| JP2014528464A5 (https=) | ||
| JP2009515831A5 (https=) | ||
| CN111315873A (zh) | 分离的重组溶瘤痘病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 | |
| JP2017526677A5 (https=) | ||
| JP2009511482A5 (https=) | ||
| JP2016512227A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| JP2021535175A5 (https=) | ||
| JP2020506884A5 (https=) | ||
| PH12017501831A1 (en) | Pharmaceutical compositions for oral administration | |
| JP2012522842A5 (https=) | ||
| EP1970078A4 (en) | COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE |